Light-induced damage to retinal pigment epithelium during pars plana vitrectomy remains a hot topic in ophthalmology. Improvements in technology led to a change of light sources, selective filters, and shorter light exposure time. Currently, there is no satisfying solution to the problem. The aim of the study was to investigate the cytoprotective effects of crocin and resveratrol on light-induced damage to primary human retinal pigment epithelial cells in vitro.
Methods:
Primary human retinal pigment epithelial cells were exposed to light analogous to the illumination during pars plana vitrectomy. To evaluate the cytoprotective effects and potential toxicity of resveratrol and crocin, human retinal pigment epithelial cells were incubated with varying concentrations of both before 3-[4,5-dimethylthiazol-2-yl] tetrazolium bromide (MTT) viability assay. Furthermore, glutathione levels were measured to investigate synergistic antioxidant potential. Apoptosis of human retinal pigment epithelial cells was determined by a nucleosome detection enzyme-linked immunosorbent assay.
Results:
Crocin and resveratrol improved cell viability in photodamaged human retinal pigment epithelial cells significantly from 40.65 ± 21.99% in illuminated human retinal pigment epithelial cells and reached a peak viability of 85.64 ± 11.37% in crocin and resveratrol pretreated cells (for all: p < 0.001). In line, the combination of the supplements increased glutathione levels significantly from 39.35 ± 21.96% to 80.74 ± 10.32% (p = 0.017). No toxic effects were detected (p > 0.99). However, no change in apoptosis rates could be observed following pretreatment with crocin and resveratrol (p > 0.99).
Conclusion:
Crocin and trans-resveratrol revealed cytoprotective effects on human retinal pigment epithelial cells supporting both supplement’s development as potential perioperative treatments in light-induced retinal pigment epithelial damage.
ChangS. LXII Edward Jackson lecture: open angle glaucoma after vitrectomy. Am J Ophthalmol2006; 141(6): 1033–1043.
2.
ReadSPFortunJA. Visualization of the retina and vitreous during vitreoretinal surgery: new technologies. Curr Opin Ophthalmol2017; 28(3): 238–241.
3.
Van den BiesenPRBerenschotTVerdaasdonkRM, et al. Endoillumination during vitrectomy and phototoxicity thresholds. Br J Ophthalmol2000; 84(12): 1372–1375.
4.
MichelsMLewisHAbramsGW, et al. Macular phototoxicity caused by fiberoptic endoillumination during pars plana vitrectomy. Am J Ophthalmol1992; 114(3): 287–296.
5.
BankerASFreemanWRKimJW, et al. Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmology1997; 104: 1442–1452; discussion 1452–1453.
6.
GlickmanRD. Phototoxicity to the retina: mechanisms of damage. Int J Toxicol2002; 21(6): 473–490.
7.
HenrichPBValmaggiaCLangC, et al. The price for reduced light toxicity: do endoilluminator spectral filters decrease color contrast during Brilliant Blue G-assisted chromovitrectomy?Graefes Arch Clin Exp Ophthalmol2014; 252(3): 367–374.
8.
Saenz-de-ViteriMHeras-MuleroHFernandez-RobredoP, et al. Oxidative stress and histological changes in a model of retinal phototoxicity in rabbits. Oxid Med Cell Longev2014; 2014: 637137.
9.
HamWTJrMuellerHARuffoloJJJr, et al. Action spectrum for retinal injury from near-ultraviolet radiation in the aphakic monkey. Am J Ophthalmol1982; 93(3): 299–306.
10.
GorgelsTGvan NorrenD. Ultraviolet and green light cause different types of damage in rat retina. Invest Ophthalmol Vis Sci1995; 36(5): 851–863.
11.
MeyersSMBonnerRF. Yellow filter to decrease the risk of light damage to the retina during vitrectomy. Am J Ophthalmol1982; 94(5): 677.
12.
MarcREJonesBWWattCB, et al. Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol Vis2008; 14: 782–806.
13.
BaksheevaVETiulinaVVTikhomirovaNK, et al. Suppression of light-induced oxidative stress in the retina by mitochondria-targeted antioxidant. Antioxidants2018; 8(1): 3.
14.
WhiteheadAJMaresJADanisRP. Macular pigment: a review of current knowledge. Arch Ophthalmol2006; 124(7): 1038–1045.
15.
JarrettSGBoultonME. Consequences of oxidative stress in age-related macular degeneration. Mol Aspects Med2012; 33(4): 399–417.
16.
TokarzPKaarnirantaKBlasiakJ. Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD). Biogerontology2013; 14(5): 461–482.
17.
SchulzJBLindenauJSeyfriedJ, et al. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem2000; 267: 4904–4911.
18.
HammondBRJohnsonBAGeorgeER. Oxidative photodegradation of ocular tissues: beneficial effects of filtering and exogenous antioxidants. Exp Eye Res2014; 129: 135–150.
19.
RozanowskaMBakkerLBoultonME, et al. Concentration dependence of vitamin C in combinations with vitamin E and zeaxanthin on light-induced toxicity to retinal pigment epithelial cells. Photochem Photobiol2012; 88(6): 1408–1417.
20.
Sousa-MartinsDMaiaMMoraesM, et al. Use of lutein and zeaxanthin alone or combined with Brilliant Blue to identify intraocular structures intraoperatively. Retina2012; 32(7): 1328–1336.
MovahedAYuLThandapillySJ, et al. Resveratrol protects adult cardiomyocytes against oxidative stress mediated cell injury. Arch Biochem Biophys2012; 527(2): 74–80.
23.
OhnoYNakanishiTUmigaiN, et al. Oral administration of crocetin prevents inner retinal damage induced by N-methyl-D-aspartate in mice. Eur J Pharmacol2012; 690(1–3): 84–89.
24.
LaabichAVissvesvaranGPLieuKL, et al. Protective effect of crocin against blue light- and white light-mediated photoreceptor cell death in bovine and primate retinal primary cell culture. Invest Ophthalmol Vis Sci2006; 47(7): 3156–3163.
25.
PinteaARuginaDPopR, et al. Antioxidant effect of trans-resveratrol in cultured human retinal pigment epithelial cells. J Ocul Pharmacol Ther2011; 27(4): 315–321.
26.
SheuS-JLiuN-CChenJL. Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J Ocul Pharmacol Ther2010; 26(3): 231–236.
27.
LvBChenTXuZ, et al. Crocin protects retinal ganglion cells against H2O2-induced damage through the mitochondrial pathway and activation of NF-kappaB. Int J Mol Med2016; 37(1): 225–232.
28.
Haghi AminjanHAbtahiSRHazratiE, et al. Targeting of oxidative stress and inflammation through ROS/NF-kappaB pathway in phosphine-induced hepatotoxicity mitigation. Life Sci2019; 232: 116607.
29.
KerntMNeubauerASLieglR, et al. Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression. J Cataract Refract Surg2009; 35(2): 354–362.
30.
SpitzerMSYoeruekESierraA, et al. Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells. Graefes Arch Clin Exp Ophthalmol2007; 245(12): 1837–1842.
31.
ChanCMHuangCHLiHJ, et al. Protective effects of resveratrol against UVA-induced damage in ARPE19 cells. Int J Mol Sci2015; 16(3): 5789–5802.
32.
KoelblPSHesslingMLingenfelderC, et al. Higher risk of light-induced retinal damage due to increase of intraocular irradiance by endoillumination. Ophthalmol Ther2019; 8(1): 41–50.
33.
HesslingMKölblPLingenfelderC, et al. Miniature LED endoilluminators for vitreoretinal surgery. In: European conference on biomedical optics, Munich, 21–25 June 2015.
34.
UedaTNakanishi-UedaTYasuharaH, et al. Eye damage control by reduced blue illumination. Exp Eye Res2009; 89(6): 863–868.
35.
McDonaldHRIrvineAR. Light-induced maculopathy from the operating microscope in extracapsular cataract extraction and intraocular lens implantation. Ophthalmology1983; 90(8): 945–951.
36.
WolffeM. How safe is the light during ophthalmic diagnosis and surgery. Eye2016; 30(2): 186–188.
37.
ContinMAAriettiMMBenedettoMM, et al. Photoreceptor damage induced by low-intensity light: model of retinal degeneration in mammals. Mol Vis2013; 19: 1614–1625.
38.
LaVailMMGorrinGMYasumuraD, et al. Increased susceptibility to constant light in NR and PCD mice with inherited retinal degenerations. Invest Ophthalmol Vis Sci1999; 40(5): 1020–1024.
39.
KortuemKGeigerLKLevinLA. Differential susceptibility of retinal ganglion cells to reactive oxygen species. Invest Ophthalmol Vis Sci2000; 41(10): 3176–3182.
40.
MoineEBrabetPGuillouL, et al. New lipophenol antioxidants reduce oxidative damage in retina pigment epithelial cells. Antioxidants2018; 7(12): 197.
41.
NarimatsuTNegishiKMiyakeS, et al. Blue light-induced inflammatory marker expression in the retinal pigment epithelium-choroid of mice and the protective effect of a yellow intraocular lens material in vivo. Exp Eye Res2015; 132: 48–51.
42.
JorgensenIRayamajhiMMiaoEA. Programmed cell death as a defence against infection. Nat Rev Immunol2017; 17(3): 151–164.
43.
JaadaneIVillalpando RodriguezGEBoulenguezP, et al. Effects of white light-emitting diode (LED) exposure on retinal pigment epithelium in vivo. J Cell Mol Med2017; 21(12): 3453–3466.
44.
WielgusARChignellCFCegerP, et al. Comparison of A2E cytotoxicity and phototoxicity with all-trans-retinal in human retinal pigment epithelial cells. Photochem Photobiol2010; 86(4): 781–791.
45.
ChenLQiYYangX. Neuroprotective effects of crocin against oxidative stress induced by ischemia/reperfusion injury in rat retina. Ophthalmic Res2015; 54(3): 157–168.
46.
KingREKentKDBomserJA. Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. Chem Biol Interact2005; 151(2): 143–149.
47.
SheuSJLiuNCOuCC, et al. Resveratrol stimulates mitochondrial bioenergetics to protect retinal pigment epithelial cells from oxidative damage. Invest Ophthalmol Vis Sci2013; 54(9): 6426–6438.
48.
AmbatiJFowlerBJ. Mechanisms of age-related macular degeneration. Neuron2012; 75: 26–39.
49.
WhitlockNCBaekSJ. The anticancer effects of resveratrol: modulation of transcription factors. Nutr Cancer2012; 64(4): 493–502.
